This inventor holds 1 USPTO granted patent. Top assignees: Schering Corporation, Other. Active years: 1998.
Company Filing History:
1 out of 1,829 
1 out of 834,411 Years Active: 1998
Title: Miguel Lopez-Botet: Innovator in Nucleic Acid Technology
Introduction
Miguel Lopez-Botet is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of biotechnology, particularly in the area of nucleic acids and their applications in diagnostics and therapeutics. His work has implications for understanding and treating various diseases.
Latest Patents
Miguel Lopez-Botet holds a patent for "Nucleic acids encoding kp43 protein and antigenic fragments thereof." This invention provides nucleic acids and polypeptides that encode an NK cell surface antigen from mammals. Additionally, it includes antibodies that specifically bind to this NK cell surface antigen. The patent outlines methods for using these nucleic acids, polypeptides, and antibodies, including the development of diagnostic kits that incorporate one or more of these reagents. He has 1 patent to his name.
Career Highlights
Throughout his career, Miguel has worked with various organizations, including Schering Corporation. His experience in the biotechnology sector has allowed him to develop innovative solutions that address critical health challenges.
Collaborations
Miguel has collaborated with notable professionals in his field, including Chiwen Chang and Jose Aramburu Beltran. These partnerships have contributed to the advancement of his research and the successful development of his inventions.
Conclusion
Miguel Lopez-Botet is a distinguished inventor whose work in nucleic acid technology has the potential to impact the medical field significantly. His contributions continue to pave the way for advancements in diagnostics and therapeutic applications.